Stay updated on IMMU-132 Clinical Trial in Epithelial Cancer
Sign up to get notified when there's something new on the IMMU-132 Clinical Trial in Epithelial Cancer page.

Latest updates to the IMMU-132 Clinical Trial in Epithelial Cancer page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedUpdate includes new version tag v3.2.0 and a government-operating-status notice; removes two specific disease terms from prior content. Overall, marks a shift in page status and less emphasis on prior disease-specific items.SummaryDifference2%
- Check23 days agoChange DetectedShift in page focus from animal mammary disease terminology to Breast Cancer, with an update to revision v3.1.0 (replacing v3.0.2).SummaryDifference0.6%
- Check38 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the Back to Top element was removed. This is a minor maintenance update with no impact on core content.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.SummaryDifference0.1%
- Check52 days agoChange DetectedThe web page has undergone significant updates, including the addition of new facility names and locations, as well as a comprehensive list of genetic and rare diseases resources. Notably, the revision number has been updated to v3.0.0.SummaryDifference6%
- Check59 days agoChange DetectedThere are no significant changes to the web page content.SummaryDifference0.4%
Stay in the know with updates to IMMU-132 Clinical Trial in Epithelial Cancer
Enter your email address, and we'll notify you when there's something new on the IMMU-132 Clinical Trial in Epithelial Cancer page.